Careers

Diversity, Equity & Inclusion

Experience

Innovation

Interactive Maps

Locations

About

Pages

Meet our team of innovators
Ask us how we do it

Professionals

Insights

Services

Thompson Hine LLP, a full-service business law firm with approximately 400 lawyers in 11 offices, was ranked number 1 in the category “Most innovative North American law firms: New working models” by The Financial Times and was 1 of 7 firms shortlisted for The American Lawyer’s inaugural Legal Services Innovation Award. The firm has been recognized by the National Law Journal as a Legal Technology Trailblazer and featured by Bloomberg for its innovative service delivery models, which drive accuracy and predictability. The firm’s commitment to innovation is embodied in Thompson Hine SmartPaTHTM – a smarter way to work – predictable, efficient and aligned with client goals. For more information, please visit ThompsonHine.com and ThompsonHine.com/SmartPaTH.

Home | Thompson Hine LLP

Atlanta

Chicago

Cincinnati

Cleveland

Columbus

Dayton

Los Angeles

Minneapolis

New York

Silicon Valley

Washington, D.C.

The Office of the U.S. Trade Representative (USTR) is seeking <a href="https://www.govinfo.gov/content/pkg/FR-2021-08-27/pdf/2021-18521.pdf">public comments</a> on whether to continue exclusions from Section 301 duties for certain medical care imports from China needed to address the COVID-19 pandemic.&nbsp; These exclusions are set to expire on September 30, 2021 (see Update of <a href="https://www.thompsonhinesmartrade.com/2021/03/ustr-again-extends-section-301-tariff-exclusions-for-certain-medical-products-from-china-necessary-for-covid-19-response/">March 8, 2021</a>).&nbsp; The USTR notice and request for public comment states:&nbsp; &ldquo;In light of developments in the production capacity of the United States in the subject products and continuing efforts in the battle against COVID&ndash;19, USTR is requesting public comments on whether to extend particular exclusions past September 30, 2021.&rdquo;
The 99 COVID-19 exclusions cover a variety of Chinese medical care products, including but not limited to: face shields; certain sterile drapes and covers; gloves; face masks; hot and cold packs; otoscopes; certain woven gauze sponges; certain non-woven fabrics; certain microscopes; certain dispensers and hand pumps for liquids; certain plastic aprons for personal protection; certain molded acrylonitrile-butadiene-styrene (ABS) tubes; certain adhesive polyethylene films, sheets and strips; and certain parts and components for X-ray and MRI equipment. These exclusions are available for any product meeting a description in the annexes accompanying USTR&rsquo;s <a href="https://ustr.gov/sites/default/files/enforcement/301Investigations/COVID_Extensions_December_2020.pdf">December 29, 2020 Federal Register</a> notice. The scope of each exclusion is determined by the 10-digit Harmonized Tariff Schedule subheadings and the product descriptions in Annexes A, B, C and D of the December 29 notice.
Written comments in support of or opposition to extending an exclusion beyond September 30, 2021 will be accepted through September 27, 2021, and must be submitted via the online portal at:&nbsp; <a href="https://comments.USTR.gov">https://comments.USTR.gov</a> under the heading &ldquo;Comments:&nbsp; Modifications to COVID-19 Exclusions.&rdquo;

core/freeform

SmarTrade

Senior Legislative and Regulatory Policy Advisor

Scott E. Diamond

International Trade

USTR Seeking Comments on Continuing Section 301 Tariff Exclusions for Certain Medical Imports from China Necessary for COVID-19 Response